More than a dozen short-sellers interviewed by Institutional Investor in an effort to penetrate this murky terrain say there are numerous players and various permutations of the model that may involve the sharing of ideas and research along with either a cut of the gains on the short trade or a set fee. In fact, some short-sellers believe that almost all of the activists have such backing — even those running small hedge funds themselves.
“Valeant had a certain reputation within the industry,” she says. “I knew it was already engaged in unethical, potentially fraudulent practice. Pharmaceuticals are a very established industry, when someone tries to disrupt it and post unusual numbers, there’s probably something wrong.”
As we’ve previously noted, German regulators have bent over backwards to accommodate Wirecard, even going so far as to discourage short sellers from targeting the stock, and launching an investigation into an FT reporter who published the first allegations about fraud within the fast-growing digital payments company.
Comment: Insiders always have deep broad advance knowledge. Wirecard appears to have some combination of internal issues AND be under attack. The plunging prices are covering the shorts. NSA has all the data but is not doing “trade intelligence” or white collar crime counterintelligence.
A whistleblower just took home $50 million — the biggest award the SEC has ever paid
CNN, 5 June 2020
The US Securities and Exchange Commission has paid out its largest-ever whistleblower award — nearly $50 million.
The whistleblower tipped off the agency to a currency manipulation scheme at a massive bank, resulting in a “successful enforcement action,” the SEC said Thursday.
The Wall Street Journal, which conducted an investigation about the scheme, reported the whistleblower is a trader from Bank of New York Mellon (BKPRC) who alerted the SEC about the bank’s reported pattern of “overcharging big clients on currency trades.”
Comment: Zero Hedge is such a shit rag when it comes to honesty about how the system works. Day Traders / retail traders you can they are facing major losses The poor bastards stand a better chance at a casino at least they will give you a FREE DRINK.. Wall St little known secret is BIG Players will counterfeit shares into their buying and when they run our of money the stocks will go straight down WELCOME TO FRAUD ST. Poor Retail investors you know them Fireman, Police ,Nurses ,Teachers, military it goes on and on we all tell them what a great job,, BUT not on our field we will take your heads off But Thanks for playing
Sorrento Therapeutics Inc (NASDAQ: SRNE) shares spiked 158% Friday after the company disclosed that it has identified an antibody that demonstrated 100% inhibition of SARS-CoV-2 virus infection.
The Sorrento Analyst
H.C. Wainwright analyst Raghuram Selvaraju has a Buy rating on Sorrento with a $24 price target.
Comment: Every placement these guys do seems to sour. Time for an investigation?
Competing Comment: Every placement is subject to naked short selling pressure, without an investigation you cannot know for sure. Some companies do have histories. HCWainwreight appears to be one of them.